id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01313533 | 12:42:treatment,43:78:treatment,83:124:treatment,129:165:treatment | First time coronary artery bypass surgery,redo coronary artery bypass surgery and combined valve repair/replacement surgery and coronary artery bypass graft surgery are eligible to participate in study | 2 | [
"First",
"time",
"coronary",
"artery",
"bypass",
"surgery",
",",
"redo",
"coronary",
"artery",
"bypass",
"surgery",
"and",
"combined",
"valve",
"repair/replacement",
"surgery",
"and",
"coronary",
"artery",
"bypass",
"graft",
"surgery",
"are",
"eligible",
"to",
"pa... | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03040778 | 12:28:cancer | Absence of tumor in the jaw at the time of recruitment | 2 | [
"Absence",
"of",
"tumor",
"in",
"the",
"jaw",
"at",
"the",
"time",
"of",
"recruitment"
] | [
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT03067051 | ,,,,134:154:treatment,156:173:chronic_disease,188:197:treatment | history of CTCAE v4 grade 3 or greater or persistent (>1 separate episode or symptoms lasting more than 3 months after initiation of medical intervention) grade 2 proctitis attributed to radiation | 2 | [
"history",
"of",
"CTCAE",
"v4",
"grade",
"3",
"or",
"greater",
"or",
"persistent",
"(",
">",
"1",
"separate",
"episode",
"or",
"symptoms",
"lasting",
"more",
"than",
"3",
"months",
"after",
"initiation",
"of",
"medical",
"intervention",
")",
"grade",
"2",
... | [
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1
] |
NCT02494869 | 25:29:cancer | Cytologically confirmed LCIS | 2 | [
"Cytologically",
"confirmed",
"LCIS"
] | [
0,
0,
3
] |
NCT01096368 | 4:19:treatment,31:52:treatment,57:72:treatment,,132:141:treatment | No prior treatment other than surgical intervention and corticosteroids; patients are allowed to have had more than one attempt at resection prior to enrollment | 2 | [
"No",
"prior",
"treatment",
"other",
"than",
"surgical",
"intervention",
"and",
"corticosteroids",
";",
"patients",
"are",
"allowed",
"to",
"have",
"had",
"more",
"than",
"one",
"attempt",
"at",
"resection",
"prior",
"to",
"enrollment"
] | [
0,
1,
1,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02548351 | 1:8:chronic_disease,, | Obesity (BMI ≥30 kg/m2) | 2 | [
"Obesity",
"(",
"BMI",
"≥30",
"kg/m2",
")"
] | [
2,
0,
0,
0,
0,
0
] |
NCT02946268 | 31:58:treatment,104:136:treatment,138:151:treatment,153:169:treatment,175:201:treatment | Patients scheduled to undergo unilateral shoulder surgery at Duke University Medical Center, including arthroscopic rotator cuff repair, acromioplasty, hemiarthroplasty, and total shoulder replacement | 2 | [
"Patients",
"scheduled",
"to",
"undergo",
"unilateral",
"shoulder",
"surgery",
"at",
"Duke",
"University",
"Medical",
"Center",
",",
"including",
"arthroscopic",
"rotator",
"cuff",
"repair",
",",
"acromioplasty",
",",
"hemiarthroplasty",
",",
"and",
"total",
"should... | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
1,
0,
1,
0,
0,
1,
1,
1
] |
NCT02131805 | 1:4:cancer,5:8:cancer,26:32:chronic_disease | BCC/SCC in area prone to trauma (including, but not limited to the skin overlying the tibia, dorsum of hands and elbow) | 2 | [
"BCC/SCC",
"in",
"area",
"prone",
"to",
"trauma",
"(",
"including",
",",
"but",
"not",
"limited",
"to",
"the",
"skin",
"overlying",
"the",
"tibia",
",",
"dorsum",
"of",
"hands",
"and",
"elbow",
")"
] | [
3,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02506192 | 1:15:chronic_disease,17:28:chronic_disease,,53:62:treatment | Kidney Disease (Hep B and C ok if after 6 months of treatment) | 2 | [
"Kidney",
"Disease",
"(",
"Hep",
"B",
"and",
"C",
"ok",
"if",
"after",
"6",
"months",
"of",
"treatment",
")"
] | [
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02581982 | 14:53:cancer,61:85:cancer,120:136:cancer,,273:288:treatment,418:426:treatment, | Known active central nervous system (CNS) metastases and/or carcinomatous meningitis; subjects with previously treated brain metastases may participate provided they are stable (without evidence of progression by imaging for at least four weeks prior to the first dose of trial treatment and any neurologic symptoms have... | 2 | [
"Known",
"active",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"metastases",
"and/or",
"carcinomatous",
"meningitis",
";",
"subjects",
"with",
"previously",
"treated",
"brain",
"metastases",
"may",
"participate",
"provided",
"they",
"are",
"stable",
"(",
"wit... | [
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT01668602 | 1:20:chronic_disease | Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking | 2 | [
"Orthopedic",
"problems",
"in",
"the",
"lower",
"limbs",
"or",
"spine",
"(",
"or",
"other",
"medical",
"conditions",
")",
"that",
"limit",
"walking"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00467987 | 33:48:chronic_disease | Any other life-threatening, non-cardiac disease | 2 | [
"Any",
"other",
"life-threatening",
",",
"non-cardiac",
"disease"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02819141 | 1:13:chronic_disease | Acute stroke | 2 | [
"Acute",
"stroke"
] | [
2,
2
] |
NCT02100722 | 1:18:chronic_disease | Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support | 2 | [
"Cardiogenic",
"shock",
"and/or",
"need",
"for",
"mechanical/pharmacologic",
"hemodynamic",
"support"
] | [
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02593526 | ,,,164:180:treatment | Expected geographic unavailability at a participating HD unit for >2 consecutive weeks or >4 weeks total during the next 6 months (excluding unavailability due to hospitalizations) | 2 | [
"Expected",
"geographic",
"unavailability",
"at",
"a",
"participating",
"HD",
"unit",
"for",
">",
"2",
"consecutive",
"weeks",
"or",
">",
"4",
"weeks",
"total",
"during",
"the",
"next",
"6",
"months",
"(",
"excluding",
"unavailability",
"due",
"to",
"hospitali... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01811368 | 36:64:chronic_disease | Patients with any of the following liver function abnormalities | 2 | [
"Patients",
"with",
"any",
"of",
"the",
"following",
"liver",
"function",
"abnormalities"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01822522 | 19:32:chronic_disease | participants with HIV infection will be eligible provided they meet the criteria | 2 | [
"participants",
"with",
"HIV",
"infection",
"will",
"be",
"eligible",
"provided",
"they",
"meet",
"the",
"criteria"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03048448 | 1:24:chronic_disease,,, | Mild hepatic impairment (Group 4): Child-Pugh Class A (5-6 points) | 2 | [
"Mild",
"hepatic",
"impairment",
"(",
"Group",
"4",
")",
":",
"Child-Pugh",
"Class",
"A",
"(",
"5-6",
"points",
")"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02323100 | 8:52:treatment | Taking pancreatic enzyme replacement therapy (PERT) | 2 | [
"Taking",
"pancreatic",
"enzyme",
"replacement",
"therapy",
"(",
"PERT",
")"
] | [
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02519322 | 7:17:cancer,,93:101:cancer,122:129:cancer,171:176:cancer,180:205:cancer,207:233:cancer,238:271:cancer,273:279:cancer,284:290:cancer,320:327:treatment,329:338:treatment | Prior malignancy active within the previous 3 years except for patient's prior diagnosis of melanoma and locally curable cancers that have been apparently cured, such as basal or squamous cell skin cancer, superficial bladder cancer, or carcinoma in situ of the prostate, cervix, or breast with local control measures (s... | 2 | [
"Prior",
"malignancy",
"active",
"within",
"the",
"previous",
"3",
"years",
"except",
"for",
"patient",
"'s",
"prior",
"diagnosis",
"of",
"melanoma",
"and",
"locally",
"curable",
"cancers",
"that",
"have",
"been",
"apparently",
"cured",
",",
"such",
"as",
"bas... | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02516813 | 30:40:treatment,44:66:treatment,,115:130:treatment | Subjects currently receiving H2-blocker or proton pump inhibitors (or unable to stop at least 5 days prior to the first treatment) | 2 | [
"Subjects",
"currently",
"receiving",
"H2-blocker",
"or",
"proton",
"pump",
"inhibitors",
"(",
"or",
"unable",
"to",
"stop",
"at",
"least",
"5",
"days",
"prior",
"to",
"the",
"first",
"treatment",
")"
] | [
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02994940 | ,,,,259:274:chronic_disease | Patients who meet UCDCH criteria for PICU admission: on home oxygen pre-operatively, exhibit airway obstruction when awake (stertor above larynx, stridor at larynx), sleep study with apnea hypoxia index greater than 25 or sleep oxygen saturation nadir <80%, cardiac disease, difficult intubation | 2 | [
"Patients",
"who",
"meet",
"UCDCH",
"criteria",
"for",
"PICU",
"admission",
":",
"on",
"home",
"oxygen",
"pre-operatively",
",",
"exhibit",
"airway",
"obstruction",
"when",
"awake",
"(",
"stertor",
"above",
"larynx",
",",
"stridor",
"at",
"larynx",
")",
",",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT03018704 | 35:51:chronic_disease | a current, clinically significant physical disease or abnormality | 2 | [
"a",
"current",
",",
"clinically",
"significant",
"physical",
"disease",
"or",
"abnormality"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT02496611 | 36:71:chronic_disease | Personal- and/or family history of multiple endocrine neoplasia type 2 | 2 | [
"Personal-",
"and/or",
"family",
"history",
"of",
"multiple",
"endocrine",
"neoplasia",
"type",
"2"
] | [
0,
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02957149 | 1:18:chronic_disease | Diabetes mellitus diagnosis | 2 | [
"Diabetes",
"mellitus",
"diagnosis"
] | [
2,
2,
0
] |
NCT01220583 | 15:48:treatment | No concurrent erythropoiesis-stimulating agents | 2 | [
"No",
"concurrent",
"erythropoiesis-stimulating",
"agents"
] | [
0,
0,
1,
1
] |
NCT02225548 | 37:66:chronic_disease,87:95:chronic_disease,104:122:chronic_disease,124:140:cancer,146:154:cancer | Subject with clinically significant chronic hematological disease which could lead to priapism such as sickle cell anemia, multiple myeloma, and leukemia | 2 | [
"Subject",
"with",
"clinically",
"significant",
"chronic",
"hematological",
"disease",
"which",
"could",
"lead",
"to",
"priapism",
"such",
"as",
"sickle",
"cell",
"anemia",
",",
"multiple",
"myeloma",
",",
"and",
"leukemia"
] | [
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
2,
0,
0,
2,
2,
2,
0,
3,
3,
0,
0,
3
] |
NCT02465060 | 15:36:treatment | documented by echocardiogram (ECHO) (as clinically indicated) | 2 | [
"documented",
"by",
"echocardiogram",
"(",
"ECHO",
")",
"(",
"as",
"clinically",
"indicated",
")"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02272998 | 1:9:chronic_disease, | GI bleed within 30 days prior to registration on study | 2 | [
"GI",
"bleed",
"within",
"30",
"days",
"prior",
"to",
"registration",
"on",
"study"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01087294 | 18:21:chronic_disease,32:43:chronic_disease,65:76:chronic_disease | Patients must be HIV negative, Hepatitis B surface antigen, and Hepatitis C antibody negative | 2 | [
"Patients",
"must",
"be",
"HIV",
"negative",
",",
"Hepatitis",
"B",
"surface",
"antigen",
",",
"and",
"Hepatitis",
"C",
"antibody",
"negative"
] | [
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02019641 | 1:18:cancer, | Metastatic cancer with a life expectancy of less than one year | 2 | [
"Metastatic",
"cancer",
"with",
"a",
"life",
"expectancy",
"of",
"less",
"than",
"one",
"year"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02291978 | 15:39:chronic_disease | Patients with inflammatory arthritides | 2 | [
"Patients",
"with",
"inflammatory",
"arthritides"
] | [
0,
0,
2,
2
] |
NCT02158793 | 112:130:treatment | Willingness to participate in ongoing psychiatric, psychological and social work evaluations prior to and post-transplant surgery | 2 | [
"Willingness",
"to",
"participate",
"in",
"ongoing",
"psychiatric",
",",
"psychological",
"and",
"social",
"work",
"evaluations",
"prior",
"to",
"and",
"post-transplant",
"surgery"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01595529 | 14:35:chronic_disease | A child with phenylketonuria (PKU) | 2 | [
"A",
"child",
"with",
"phenylketonuria",
"(",
"PKU",
")"
] | [
0,
0,
0,
2,
2,
0,
0
] |
NCT02579096 | 1:25:cancer | non-melanoma skin cancer | 2 | [
"non-melanoma",
"skin",
"cancer"
] | [
3,
3,
3
] |
NCT02143726 | 13:37:treatment,43:61:cancer,65:107:treatment,, | Presence of fluorodeoxyglucose (FDG) avid metastatic lesions on positron emission tomography (PET)/CT scan (standardized uptake values [SUV]max > 5 of any single lesion) | 2 | [
"Presence",
"of",
"fluorodeoxyglucose",
"(",
"FDG",
")",
"avid",
"metastatic",
"lesions",
"on",
"positron",
"emission",
"tomography",
"(",
"PET",
")",
"/CT",
"scan",
"(",
"standardized",
"uptake",
"values",
"[",
"SUV",
"]",
"max",
">",
"5",
"of",
"any",
"s... | [
0,
0,
1,
1,
0,
0,
0,
3,
3,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03056287 | ,47:53:chronic_disease | Unable to ambulate at least 150 feet prior to stroke | 2 | [
"Unable",
"to",
"ambulate",
"at",
"least",
"150",
"feet",
"prior",
"to",
"stroke"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02285101 | 8:31:treatment, | Use of investigational drug(s) within 4 weeks of enrollment | 2 | [
"Use",
"of",
"investigational",
"drug",
"(",
"s",
")",
"within",
"4",
"weeks",
"of",
"enrollment"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02946892 | 29:40:treatment,,76:90:treatment,92:116:treatment,118:132:treatment,134:147:treatment,149:161:treatment,163:173:treatment,175:184:treatment,186:196:treatment,198:209:treatment,211:218:treatment,223:247:treatment | Use of any of the following medications within two weeks of randomization: MAO inhibitors, Calcium channel blockers, alpha blockers, beta blockers, disopyramide, flecainide, encainide, moricizine, propafenone, sotalol, or beta adrenergic agonists | 2 | [
"Use",
"of",
"any",
"of",
"the",
"following",
"medications",
"within",
"two",
"weeks",
"of",
"randomization",
":",
"MAO",
"inhibitors",
",",
"Calcium",
"channel",
"blockers",
",",
"alpha",
"blockers",
",",
"beta",
"blockers",
",",
"disopyramide",
",",
"flecain... | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
0,
1,
1,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0
] |
NCT03181516 | 1:12:treatment | Amoxicillin | 2 | [
"Amoxicillin"
] | [
1
] |
NCT01059786 | ,46:64:cancer,100:104:treatment,112:117:treatment | Patients with flow cytometry consistent with HCL variant (HCLv) are eligible, including those with CD25 and/or CD103 negative disease | 2 | [
"Patients",
"with",
"flow",
"cytometry",
"consistent",
"with",
"HCL",
"variant",
"(",
"HCLv",
")",
"are",
"eligible",
",",
"including",
"those",
"with",
"CD25",
"and/or",
"CD103",
"negative",
"disease"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0
] |
NCT02541903 | 13:37:cancer | Previous or concomitant malignancies at other sites | 2 | [
"Previous",
"or",
"concomitant",
"malignancies",
"at",
"other",
"sites"
] | [
0,
0,
3,
3,
0,
0,
0
] |
NCT02945800 | 1:37:chronic_disease | symptomatic congestive heart failure | 2 | [
"symptomatic",
"congestive",
"heart",
"failure"
] | [
2,
2,
2,
2
] |
NCT02536846 | 11:28:chronic_disease,43:55:chronic_disease,64:75:chronic_disease,77:100:chronic_disease,102:120:chronic_disease,122:130:chronic_disease,132:148:chronic_disease,176:197:chronic_disease,199:219:chronic_disease,271:284:allergy_name | Diagnosis diabetes mellitus, uncontrolled hypertension, severe hypotension, coronary artery disease, metabolic syndrome, glaucoma, liver impairment, decreased renal function, respiratory disorders, peptic ulcer disease (absolute and relative contraindications to use of antipsychotic drugs) | 2 | [
"Diagnosis",
"diabetes",
"mellitus",
",",
"uncontrolled",
"hypertension",
",",
"severe",
"hypotension",
",",
"coronary",
"artery",
"disease",
",",
"metabolic",
"syndrome",
",",
"glaucoma",
",",
"liver",
"impairment",
",",
"decreased",
"renal",
"function",
",",
"re... | [
0,
2,
2,
0,
0,
2,
0,
0,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0
] |
NCT00501826 | 13:15:chronic_disease, | patients in CR after =< 2 courses are also eligible | 2 | [
"patients",
"in",
"CR",
"after",
"=",
"<",
"2",
"courses",
"are",
"also",
"eligible"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01872975 | 44:50:cancer,67:89:cancer,105:109:cancer,123:140:treatment | Any prior history, not including the index cancer, of ipsilateral invasive breast cancer or ipsilateral DCIS treated with radiation therapy | 2 | [
"Any",
"prior",
"history",
",",
"not",
"including",
"the",
"index",
"cancer",
",",
"of",
"ipsilateral",
"invasive",
"breast",
"cancer",
"or",
"ipsilateral",
"DCIS",
"treated",
"with",
"radiation",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
3,
3,
3,
0,
0,
3,
0,
0,
1,
1
] |
NCT02389465 | 21:46:chronic_disease | DSM-IV criteria for Major Depressive Disorder | 2 | [
"DSM-IV",
"criteria",
"for",
"Major",
"Depressive",
"Disorder"
] | [
0,
0,
0,
2,
2,
2
] |
NCT03061201 | ,23:37:chronic_disease,41:53:treatment,91:102:chronic_disease,119:140:chronic_disease | Presence of > grade 2 liver fibrosis on elastography for subjects with history of treated Hepatitis C or suspicion of chronic liver disease | 2 | [
"Presence",
"of",
">",
"grade",
"2",
"liver",
"fibrosis",
"on",
"elastography",
"for",
"subjects",
"with",
"history",
"of",
"treated",
"Hepatitis",
"C",
"or",
"suspicion",
"of",
"chronic",
"liver",
"disease"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
1,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2
] |
NCT01983462 | 12:26:chronic_disease,28:46:chronic_disease,48:57:chronic_disease,66:104:chronic_disease,109:127:chronic_disease | History of gastric ulcers, bleeding disorders, dyspepsia, severe gastroesophageal reflux disease (GERD), or metabolic acidosis | 2 | [
"History",
"of",
"gastric",
"ulcers",
",",
"bleeding",
"disorders",
",",
"dyspepsia",
",",
"severe",
"gastroesophageal",
"reflux",
"disease",
"(",
"GERD",
")",
",",
"or",
"metabolic",
"acidosis"
] | [
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2
] |
NCT02159560 | 21:45:treatment | Contraindication to epidural catheterization | 2 | [
"Contraindication",
"to",
"epidural",
"catheterization"
] | [
0,
0,
1,
1
] |
NCT03049189 | 1:47:chronic_disease | Somatostatin receptor positive (SSTR+) disease | 2 | [
"Somatostatin",
"receptor",
"positive",
"(",
"SSTR+",
")",
"disease"
] | [
2,
2,
2,
2,
2,
0,
0
] |
NCT01648023 | 84:101:treatment | that would place the patient at undue risk and that would preclude the safe use of chemoembolization or would interfere with study participation | 2 | [
"that",
"would",
"place",
"the",
"patient",
"at",
"undue",
"risk",
"and",
"that",
"would",
"preclude",
"the",
"safe",
"use",
"of",
"chemoembolization",
"or",
"would",
"interfere",
"with",
"study",
"participation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02417701 | ,55:71:treatment | Patients must have completed at least 1 prior line of systemic therapy | 2 | [
"Patients",
"must",
"have",
"completed",
"at",
"least",
"1",
"prior",
"line",
"of",
"systemic",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02655614 | 18:27:treatment,,, | Currently taking edaravone unless after completion of at least the second 14-day drug-treatment period, as long as Day 1 occurs during a drug-free period at least 24 hours after the last edaravone dose and at least 5 days prior to the first dose of the next cycle | 2 | [
"Currently",
"taking",
"edaravone",
"unless",
"after",
"completion",
"of",
"at",
"least",
"the",
"second",
"14-day",
"drug-treatment",
"period",
",",
"as",
"long",
"as",
"Day",
"1",
"occurs",
"during",
"a",
"drug-free",
"period",
"at",
"least",
"24",
"hours",
... | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03104699 | 1:34:chronic_disease, | cerebral vascular accident/stroke (<6 months before enrollment) | 2 | [
"cerebral",
"vascular",
"accident/stroke",
"(",
"<",
"6",
"months",
"before",
"enrollment",
")"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01568255 | 1:15:chronic_disease | Myopathic pain that cannot be attributed to other medical conditions | 2 | [
"Myopathic",
"pain",
"that",
"can",
"not",
"be",
"attributed",
"to",
"other",
"medical",
"conditions"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01782599 | 19:53:treatment,, | Be willing to use Nicotine Replacement Therapy (NRT) and the e-cigarette for a period of 2 to 3 weeks | 2 | [
"Be",
"willing",
"to",
"use",
"Nicotine",
"Replacement",
"Therapy",
"(",
"NRT",
")",
"and",
"the",
"e-cigarette",
"for",
"a",
"period",
"of",
"2",
"to",
"3",
"weeks"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730794 | 1:10:chronic_disease | Hypoxemic or hypercapnic acute respiratory failure | 2 | [
"Hypoxemic",
"or",
"hypercapnic",
"acute",
"respiratory",
"failure"
] | [
2,
0,
0,
0,
0,
0
] |
NCT03042689 | 1:26:cancer | superficial bladder tumor | 2 | [
"superficial",
"bladder",
"tumor"
] | [
3,
3,
3
] |
NCT01681264 | 24:46:chronic_disease,53:63:chronic_disease,,,98:121:chronic_disease,123:130:chronic_disease,134:150:chronic_disease,152:165:chronic_disease,167:186:chronic_disease,202:209:chronic_disease | Has known pre-existing cardiovascular disease (i.e. arrhythmia - prolonged QT interval > 440ms), cerebrovascular disease, hepatic or renal impairment, CNS condition, metabolic condition, or history of syncope | 2 | [
"Has",
"known",
"pre-existing",
"cardiovascular",
"disease",
"(",
"i.e",
".",
"arrhythmia",
"-",
"prolonged",
"QT",
"interval",
">",
"440ms",
")",
",",
"cerebrovascular",
"disease",
",",
"hepatic",
"or",
"renal",
"impairment",
",",
"CNS",
"condition",
",",
"me... | [
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
2
] |
NCT02919436 | 1:14:chronic_disease | Renal failure | 2 | [
"Renal",
"failure"
] | [
2,
2
] |
NCT02946892 | 1:22:chronic_disease | primary aldosteronism | 2 | [
"primary",
"aldosteronism"
] | [
2,
2
] |
NCT01940757 | ,39:75:treatment, | Pregnancy as determined by a positive urine human choriogonadotropin (hCG) (if female) | 2 | [
"Pregnancy",
"as",
"determined",
"by",
"a",
"positive",
"urine",
"human",
"choriogonadotropin",
"(",
"hCG",
")",
"(",
"if",
"female",
")"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02379520 | 69:83:treatment,, | Currently receiving any investigational agents or have received any tumor vaccines or T cell antibodies within previous 4 weeks | 2 | [
"Currently",
"receiving",
"any",
"investigational",
"agents",
"or",
"have",
"received",
"any",
"tumor",
"vaccines",
"or",
"T",
"cell",
"antibodies",
"within",
"previous",
"4",
"weeks"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01618357 | 30:46:treatment | Unable to swallow and retain oral medications | 2 | [
"Unable",
"to",
"swallow",
"and",
"retain",
"oral",
"medications"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT02445339 | 22:37:treatment,76:85:treatment,95:122:chronic_disease | Currently prescribed pharmacotherapy for alcohol dependence (not including treatment of acute alcohol withdrawal syndrome) | 2 | [
"Currently",
"prescribed",
"pharmacotherapy",
"for",
"alcohol",
"dependence",
"(",
"not",
"including",
"treatment",
"of",
"acute",
"alcohol",
"withdrawal",
"syndrome",
")"
] | [
0,
0,
1,
0,
2,
2,
2,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01367444 | ,,,107:131:treatment | Males must agree with their partner to use two forms of contraception for at least three months following SAR422459 administration | 2 | [
"Males",
"must",
"agree",
"with",
"their",
"partner",
"to",
"use",
"two",
"forms",
"of",
"contraception",
"for",
"at",
"least",
"three",
"months",
"following",
"SAR422459",
"administration"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02582827 | ,44:65:chronic_disease,69:77:chronic_disease,81:105:chronic_disease | History (within prior 24 months) of either myocardial infarction or unstable or poorly controlled angina | 2 | [
"History",
"(",
"within",
"prior",
"24",
"months",
")",
"of",
"either",
"myocardial",
"infarction",
"or",
"unstable",
"or",
"poorly",
"controlled",
"angina"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
2
] |
NCT02226341 | 19:25:chronic_disease,, | Moderately severe anemia (Hgb < 8 mg/dL) | 2 | [
"Moderately",
"severe",
"anemia",
"(",
"Hgb",
"<",
"8",
"mg/dL",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02981082 | 1:12:chronic_disease | Sarcoidosis | 2 | [
"Sarcoidosis"
] | [
2
] |
NCT03034213 | 7:24:cancer,44:56:treatment,,,156:176:cancer,178:201:cancer,206:229:cancer | Known active malignancy present and/or had chemotherapy 12 weeks prior to screening or planned chemotherapy within 12 weeks of treatment with exception of basal cell carcinoma, squamous cell carcinoma, or prostate cancer in situ | 2 | [
"Known",
"active",
"malignancy",
"present",
"and/or",
"had",
"chemotherapy",
"12",
"weeks",
"prior",
"to",
"screening",
"or",
"planned",
"chemotherapy",
"within",
"12",
"weeks",
"of",
"treatment",
"with",
"exception",
"of",
"basal",
"cell",
"carcinoma",
",",
"sq... | [
0,
3,
3,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3,
3,
3
] |
NCT02932410 | 1:16:chronic_disease | schistosomiasis | 2 | [
"schistosomiasis"
] | [
2
] |
NCT01238120 | ,57:80:treatment, | Be scheduled to receive at least 2 additional cycles of oral or IV chemotherapy over the 42-day study period | 2 | [
"Be",
"scheduled",
"to",
"receive",
"at",
"least",
"2",
"additional",
"cycles",
"of",
"oral",
"or",
"IV",
"chemotherapy",
"over",
"the",
"42-day",
"study",
"period"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03126370 | 18:21:treatment,28:37:treatment,42:79:treatment,109:118:treatment,122:125:chronic_disease | Have been taking TDF and a ritonavir- or cobicistat-boosted protease inhibitor as part of standard care for treatment of HIV | 2 | [
"Have",
"been",
"taking",
"TDF",
"and",
"a",
"ritonavir-",
"or",
"cobicistat-boosted",
"protease",
"inhibitor",
"as",
"part",
"of",
"standard",
"care",
"for",
"treatment",
"of",
"HIV"
] | [
0,
0,
0,
1,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
2
] |
NCT02703272 | 41:59:chronic_disease | Participants with inherited or acquired bleeding disorders | 2 | [
"Participants",
"with",
"inherited",
"or",
"acquired",
"bleeding",
"disorders"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02429830 | ,,107:114:treatment | If the subject is of child bearing potential must have a negative pregnancy test within one week prior to implant and must agree to use effective means of birth control during the course of the study | 2 | [
"If",
"the",
"subject",
"is",
"of",
"child",
"bearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"within",
"one",
"week",
"prior",
"to",
"implant",
"and",
"must",
"agree",
"to",
"use",
"effective",
"means",
"of",
"birth",
"control",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03114020 | 1:43:chronic_disease, | Upper or lower respiratory tract infection within 2 weeks prior to screening and baseline (day1) | 2 | [
"Upper",
"or",
"lower",
"respiratory",
"tract",
"infection",
"within",
"2",
"weeks",
"prior",
"to",
"screening",
"and",
"baseline",
"(",
"day1",
")"
] | [
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02323581 | 27:36:chronic_disease | Serious systemic or groin infection | 2 | [
"Serious",
"systemic",
"or",
"groin",
"infection"
] | [
0,
0,
0,
0,
2
] |
NCT02130687 | 1:10:treatment, | Treatment with any investigational drug in the 1 month preceding the study | 2 | [
"Treatment",
"with",
"any",
"investigational",
"drug",
"in",
"the",
"1",
"month",
"preceding",
"the",
"study"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578901 | 13:21:treatment | Subjects on dialysis | 2 | [
"Subjects",
"on",
"dialysis"
] | [
0,
0,
1
] |
NCT02437370 | 24:34:cancer,74:83:treatment,104:136:cancer,138:173:cancer,178:201:cancer,233:249:treatment, | Has a known additional malignancy that is progressing or requires active treatment; exceptions include basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or in situ cervical cancer that has undergone potentially curative therapy; free of disease for more than 5 years | 2 | [
"Has",
"a",
"known",
"additional",
"malignancy",
"that",
"is",
"progressing",
"or",
"requires",
"active",
"treatment",
";",
"exceptions",
"include",
"basal",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"... | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01801072 | 18:24:chronic_disease | History of prior stroke | 2 | [
"History",
"of",
"prior",
"stroke"
] | [
0,
0,
0,
2
] |
NCT02562235 | 1:32:chronic_disease,, | Pulmonary arterial hypertension confirmed by a RHC at any time prior to start of study, with mean pulmonary artery pressure (PAPmean) ≥25 mmHg at rest | 2 | [
"Pulmonary",
"arterial",
"hypertension",
"confirmed",
"by",
"a",
"RHC",
"at",
"any",
"time",
"prior",
"to",
"start",
"of",
"study",
",",
"with",
"mean",
"pulmonary",
"artery",
"pressure",
"(",
"PAPmean",
")",
"≥25",
"mmHg",
"at",
"rest"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02354703 | 60:71:allergy_name | History of severe or life-threatening adverse reactions to ondansetron | 2 | [
"History",
"of",
"severe",
"or",
"life-threatening",
"adverse",
"reactions",
"to",
"ondansetron"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT02822378 | 1:10:treatment | denosumab at any time | 2 | [
"denosumab",
"at",
"any",
"time"
] | [
1,
0,
0,
0
] |
NCT03175159 | 21:38:chronic_disease | Discovery of active suicidal ideation at the time of interview (participants will be referred immediately for treatment, but may join the study once resolved) | 2 | [
"Discovery",
"of",
"active",
"suicidal",
"ideation",
"at",
"the",
"time",
"of",
"interview",
"(",
"participants",
"will",
"be",
"referred",
"immediately",
"for",
"treatment",
",",
"but",
"may",
"join",
"the",
"study",
"once",
"resolved",
")"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02321501 | 1:23:cancer,38:52:cancer,87:94:treatment, | Non-ALK-positive NSCLC patients with CNS metastasis should have completed a course of therapy would be eligible for the study provided they are clinically stable for 1 month | 2 | [
"Non-ALK-positive",
"NSCLC",
"patients",
"with",
"CNS",
"metastasis",
"should",
"have",
"completed",
"a",
"course",
"of",
"therapy",
"would",
"be",
"eligible",
"for",
"the",
"study",
"provided",
"they",
"are",
"clinically",
"stable",
"for",
"1",
"month"
] | [
3,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02269293 | 22:32:chronic_disease, | Neurologic function: Neuropathy (sensory and motor) less than or equal to Grade 1 | 2 | [
"Neurologic",
"function",
":",
"Neuropathy",
"(",
"sensory",
"and",
"motor",
")",
"less",
"than",
"or",
"equal",
"to",
"Grade",
"1"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01941316 | ,66:93:treatment | Patients who progressed during or within one month of completing platinum-based chemotherapy | 2 | [
"Patients",
"who",
"progressed",
"during",
"or",
"within",
"one",
"month",
"of",
"completing",
"platinum-based",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01842399 | 45:54:allergy_name | Allergy or intolerance to local anesthetic- Lidocaine | 2 | [
"Allergy",
"or",
"intolerance",
"to",
"local",
"anesthetic-",
"Lidocaine"
] | [
0,
0,
0,
0,
0,
0,
4
] |
NCT01754857 | 28:39:chronic_disease,96:105:allergy_name,115:142:allergy_name | Severe or life-threatening anaphylaxis or hypersensitivity reaction when previously exposed to rituximab or other monoclonal antibody therapy | 2 | [
"Severe",
"or",
"life-threatening",
"anaphylaxis",
"or",
"hypersensitivity",
"reaction",
"when",
"previously",
"exposed",
"to",
"rituximab",
"or",
"other",
"monoclonal",
"antibody",
"therapy"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
4,
4,
4
] |
NCT02101736 | 39:54:chronic_disease,111:132:chronic_disease,147:159:chronic_disease,168:177:chronic_disease,179:198:chronic_disease,200:230:chronic_disease,239:264:chronic_disease | Concurrent severe and/or uncontrolled medical disease which could compromise participation in the study (e.g. uncontrolled diabetes, uncontrolled hypertension, severe infection, severe malnutrition, chronic liver or renal disease, active upper GI tract ulceration) | 2 | [
"Concurrent",
"severe",
"and/or",
"uncontrolled",
"medical",
"disease",
"which",
"could",
"compromise",
"participation",
"in",
"the",
"study",
"(",
"e.g",
".",
"uncontrolled",
"diabetes",
",",
"uncontrolled",
"hypertension",
",",
"severe",
"infection",
",",
"severe"... | [
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
2,
2,
2,
2,
0
] |
NCT02158858 | ,,44:70:treatment | ANC ≥ 1 x 10^9/L without the assistance of granulocyte growth factors | 2 | [
"ANC",
"≥",
"1",
"x",
"10^9/L",
"without",
"the",
"assistance",
"of",
"granulocyte",
"growth",
"factors"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02094625 | 9:18:treatment,, | Planned cisplatin dose to be infused over ≤6 hours for ≤2 days per cycle | 2 | [
"Planned",
"cisplatin",
"dose",
"to",
"be",
"infused",
"over",
"≤6",
"hours",
"for",
"≤2",
"days",
"per",
"cycle"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02314221 | 1:13:chronic_disease,, | Brain injury with score on mini-mental status examination less than 26 | 2 | [
"Brain",
"injury",
"with",
"score",
"on",
"mini-mental",
"status",
"examination",
"less",
"than",
"26"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02837510 | 1:27:treatment | Anti-psychotic medications | 2 | [
"Anti-psychotic",
"medications"
] | [
1,
1
] |
NCT02519283 | 13:16:chronic_disease | Evidence of ACS based on ischemia on ECG or Troponin elevation | 2 | [
"Evidence",
"of",
"ACS",
"based",
"on",
"ischemia",
"on",
"ECG",
"or",
"Troponin",
"elevation"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02446457 | 26:45:cancer,,93:115:treatment,130:139:treatment,150:174:treatment | with histologic proof of follicular lymphoma grade 1, 2, or 3a relapsing after at least one prior systemic therapy that included rituximab (or other monoclonal CD20 antibody) | 2 | [
"with",
"histologic",
"proof",
"of",
"follicular",
"lymphoma",
"grade",
"1",
",",
"2",
",",
"or",
"3a",
"relapsing",
"after",
"at",
"least",
"one",
"prior",
"systemic",
"therapy",
"that",
"included",
"rituximab",
"(",
"or",
"other",
"monoclonal",
"CD20",
"an... | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
0,
0,
0,
1,
1,
1,
0
] |
NCT02327312 | 1:12:chronic_disease | choroiditis | 2 | [
"choroiditis"
] | [
2
] |
NCT01614197 | ,64:73:treatment | At least 3 half-lives must have elapsed after the last dose of GVHD meds | 2 | [
"At",
"least",
"3",
"half-lives",
"must",
"have",
"elapsed",
"after",
"the",
"last",
"dose",
"of",
"GVHD",
"meds"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.